Clinical Trials on Papillomavirus Vaccines

Total 1769 results

University of Alabama at Birmingham
National Cancer Institute (NCI)

Recruiting

Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

Papillomavirus Vaccines

United States
Huong McLean, PhD
Centers for Disease Control and Prevention

Active, not recruiting

Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination

Papillomavirus Vaccines

United States
Washington University School of Medicine
National Cancer Institute (NCI)

Completed

Increasing Optimal Use of HPV Vaccination in Primary Care

Human Papillomavirus Vaccines

United States
Arizona State University
National Institute on Minority Health and Health Disparities (NIMHD); Adelante...

Completed

Community Pharmacists Vaccinate Against Cancer (CPVAC)

Human Papillomavirus Vaccines

United States
University of Texas Southwestern Medical Center
National Cancer Institute (NCI); Southern Methodist University; Parkland Health...

Terminated

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial

Human Papillomavirus Vaccines

United States
Laval University
Centers for Disease Control and Prevention

Completed

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Human Papillomavirus Vaccines

Canada
University of Cincinnati

Recruiting

Let's K-Talk - HPV Study for Ethnic Koreans

Papillomavirus Vaccines | Human Papillomavirus Viruses

United States
Xiamen Innovax Biotech Co., Ltd

Completed

Immunogenicity and Safety of One Dose of HPV Vaccine

Human Papillomavirus Vaccines

China
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Not yet recruiting

HPV Vaccine Confident Families

Human Papillomavirus Vaccines
University of Texas Southwestern Medical Center
National Cancer Institute (NCI); Southern Methodist University; Parkland Health...

Completed

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination

Human Papillomavirus Vaccines

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children

Vaccines, Pneumococcal | Vaccines, Pneumococcal Conjugate Vaccine
University of Florida
Patient-Centered Outcomes Research Institute; National Cancer Institute (NCI)

Not yet recruiting

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Human Papillomavirus (HPV) Vaccines

United States
GlaxoSmithKline

Completed

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Infections, Papillomavirus | Papillomavirus Vaccines

Belgium, United States
GlaxoSmithKline

Completed

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

Infections, Papillomavirus | Papillomavirus Vaccines

Denmark, Poland, Lithuania
University of Pittsburgh
Merck Sharp & Dohme LLC

Completed

Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting

Quadrivalent HPV Vaccine | Human Papillomavirus Vaccine

United States
University of North Carolina, Chapel Hill
Harvard Medical School (HMS and HSDM); Robert Wood Johnson Foundation; Michigan... and other collaborators

Completed

AFIX to Improve HPV Vaccination (AFIX)

Papillomavirus Vaccines | Adolescent Health Services

United States
Pfizer

Completed

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Vaccines, Pneumococcal Conjugate Vaccine

United States, Spain, France, Canada, Germany, Czechia, Sweden, Belgium, Poland, Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

Vaccines, Pneumococcal Conjugate Vaccine

South Africa
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

Vaccines, Pneumococcal Conjugate Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Prevenar Immunogenicity in High Risk Children

Vaccines, Pneumococcal Conjugate Vaccine
Milton S. Hershey Medical Center
National Cancer Institute (NCI)

Active, not recruiting

HPV Vaccine Communication ECHO for Primary Care Clinics

Human Papillomavirus Vaccines | Adolescent Health Services

United States
London School of Hygiene and Tropical Medicine
Merck Sharp & Dohme LLC; Public Health England; University of Cambridge

Active, not recruiting

HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial (HPV)

Human Papillomavirus Vaccine

Gambia
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016)

Vaccines, Combined | Hexavalent Vaccine

Germany, Italy, Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil

Vaccines, Pneumococcal Conjugate Vaccine

Brazil
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants

Vaccines, Pneumococcal Conjugate Vaccine

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

Vaccines, Pneumococcal Conjugate Vaccine

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)

Vaccines, Pneumococcal Conjugate Vaccine

Philippines
National Institute for Control of Vaccine and Biologicals

Unknown

Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule (HPV-022 PRI)

Human Papillomavirus (HPV) Vaccine

Vietnam
Fujian Maternity and Child Health Hospital

Recruiting

Study on the Epidemiological Characteristics of Female HPV Vaccination in China

Adverse Effect | Epidemiology | Woman | Human Papillomavirus Vaccines | China

China
Pfizer

Completed

A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older

Pneumococcal Vaccines | Pneumococcal Conjugate Vaccine

Japan
Mayo Clinic
National Cancer Institute (NCI)

Completed

Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination

Papillomavirus Vaccines

United States
Kanazawa Medical University
Merck Sharp & Dohme LLC

Unknown

Changes in the Prevalence of Oncogenic HPV Types

Papillomavirus Infections | Papillomavirus Vaccines
Fujian Maternity and Child Health Hospital

Recruiting

A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women

Efficacy, Self | Adverse Effect | Woman | Human Papillomavirus Vaccines | China

China
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Vaccines | Pneumococcal Conjugate Vaccine

Taiwan
University of Pennsylvania

Completed

Testing the Persuasiveness of Pro-inoculation Arguments

Vaccine Refusal | Vaccination Hesitancy | Human Papillomavirus Vaccination

United States
GlaxoSmithKline

Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Infections, Papillomavirus | Papillomavirus Vaccines

United States
GlaxoSmithKline

Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Infections, Papillomavirus | Papillomavirus Vaccines

Germany, Taiwan, Colombia, Panama, Honduras
GlaxoSmithKline

Completed

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

Infections, Papillomavirus | Papillomavirus Vaccines

United States, Russian Federation, Canada, Singapore, Netherlands, United Kingdom, Thailand, Australia, Philippines, Mexico, Portugal, Peru
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Infections, Papillomavirus | Papillomavirus Vaccines

Belgium
Children's Hospital of Philadelphia
Noble Medical, LLC

Completed

Video to Promote HPV Vaccination

Health Behavior | Human Papillomavirus | Acceptance Processes | Social Acceptance | Vaccine Acceptance

United States
Eastern Virginia Medical School
Merck Sharp & Dohme LLC

Recruiting

Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination

Papillomavirus Vaccines

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)

Prevention | Papillomavirus Infection | Healthy Adult Female Participants | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Duke University
Centers for Disease Control and Prevention

Completed

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

Pertussis | Influenza Vaccine | Papillomavirus Infection

United States
Indiana University

Completed

Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents

Influenza Vaccines | Human Papillomavirus Vaccines | Attitude to Health
Assistance Publique - Hôpitaux de Paris

Recruiting

Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease (MC-HPV)

Human Papillomavirus Vaccine | Chronic Condition

France
University of California, Los Angeles
Centers for Disease Control and Prevention

Completed

Testing the Use of Prompts to Increase Adolescent Immunization Rates (AIMHi)

Pertussis | Influenza | Human Papillomavirus | Meningococcal Disease | Vaccine Preventable Diseases

United States
Centers for Disease Control and Prevention, China

Recruiting

Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 (QIV;PPV23)

Pneumococcal Vaccines | Safety | Influenza Vaccines | COVID-19 Vaccines | Immunogenicity, Vaccine

China
Sinocelltech Ltd.

Recruiting

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

HPV Infection Vaccine Safety SCT1000

China
The Behavioural Insights Team
UNICEF; National Center for Disease Control and Public Health, Georgia; Information...

Not yet recruiting

SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine
Bandim Health Project

Active, not recruiting

OPV as Potential Protection Against COVID-19

Mortality | COVID | Morbidity | Poliovirus Vaccine, Oral | Non-Specific Effects of Vaccines

Guinea-Bissau

Clinical Trials on Papillomavirus Vaccines

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations